Sanz AB, Sanchez-Niño MD, Ramos AM, Ortiz A (2023) Regulated cell death pathways in kidney disease. Nat Rev Nephrol 19:281–299. https://doi.org/10.1038/s41581-023-00694-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Zhang H, Yi X, Dou Q (2024) Cellular senescence of renal tubular epithelial cells in acute kidney injury. Cell Death Discov 10:62. https://doi.org/10.1038/s41420-024-01831-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolbrink B, von Samson-Himmelstjerna FA, Murphy JM, Krautwald S (2023) Role of necroptosis in kidney health and disease. Nat Rev Nephrol 19:300–314. https://doi.org/10.1038/s41581-022-00658-w

Article  PubMed  Google Scholar 

Jin Q, Ma F, Liu T, Yang L (2024) Sirtuins in kidney diseases: potential mechanism and therapeutic targets. Cell Commun Signal 22:114. https://doi.org/10.1186/s12964-023-01442-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Yu X, Liu D, Qiao Y (2024) VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh) 11:e2305563. https://doi.org/10.1002/advs.202305563

Article  CAS  PubMed  Google Scholar 

Liu L, Bai F, Song H, Xiao R (2022) Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol 50:102260. https://doi.org/10.1016/j.redox.2022.102260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang S, Su H (2023) Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease. Cell Commun Signal 21:288. https://doi.org/10.1186/s12964-023-01323-w

Article  PubMed  PubMed Central  Google Scholar 

Choi EH, Park SJ (2023) TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med 55:1348–1356. https://doi.org/10.1038/s12276-023-01019-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu F, Cai Z, Bai J, Fan L (2022) The adipocyte-enriched secretory protein tetranectin exacerbates type 2 diabetes by inhibiting insulin secretion from β cells. Sci Adv 8:eabq1799. https://doi.org/10.1126/sciadv.abq1799

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schneider MR, Zettler S, Rathkolb B, Dahlhoff M (2023) TXNIP overexpression in mice enhances streptozotocin-induced diabetes severity. Mol Cell Endocrinol 565:111885. https://doi.org/10.1016/j.mce.2023.111885

Article  CAS  PubMed  Google Scholar 

Lian L, Le Z, Wang Z, Chen YA (2023) SIRT1 inhibits high glucose-induced TXNIP/NLRP3 inflammasome activation and cataract formation. Invest Ophthalmol Vis Sci 64:16. https://doi.org/10.1167/iovs.64.3.16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Liu L, Zhang Y, Yuan Y (2022) ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation. Redox Biol 58:102554. https://doi.org/10.1016/j.redox.2022.102554

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Deng W, Wu J, He Q (2023) TXNIP exacerbates the senescence and aging-related dysfunction of β cells by inducing cell cycle arrest through p38–p16/p21-CDK-Rb pathway. Antioxid Redox Signal 38:480–495. https://doi.org/10.1089/ars.2021.0224

Article  CAS  PubMed  Google Scholar 

Song S, Qiu D, Shi Y, Wang S (2019) Thioredoxin-interacting protein deficiency alleviates phenotypic alterations of podocytes via inhibition of mTOR activation in diabetic nephropathy. J Cell Physiol 234:16485–16502. https://doi.org/10.1002/jcp.28317

Article  CAS  PubMed  Google Scholar 

Gao P, He FF, Tang H, Lei CT (2015) NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia. J Diabetes Res 2015:504761. https://doi.org/10.1155/2015/504761

Article  PubMed  PubMed Central  Google Scholar 

Zhou D, Li X, Xiao X, Wang G (2023) Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus. Phytomedicine 110:154634. https://doi.org/10.1016/j.phymed.2022.154634

Article  CAS  PubMed  Google Scholar 

Li A, Guan L, Su W, Zhao N (2023) TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives. J Enzyme Inhib Med Chem 38:2166937. https://doi.org/10.1080/14756366.2023.2166937

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Q, Chen J, Zeng A, Song L (2023) Pharmacological functions of salidroside in renal diseases: facts and perspectives. Front Pharmacol 14:1309598. https://doi.org/10.3389/fphar.2023.1309598

Article  CAS  PubMed  Google Scholar 

Zhang M, Hu G, Shao N, Qin Y (2021) Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer’s disease: flavonoids and phenols. Inflammopharmacology 29:1317–1329. https://doi.org/10.1007/s10787-021-00861-4

Article  CAS  PubMed  Google Scholar 

Fang S, Dong L, Liu L, Guo J (2021) HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res 49:D1197-d1206. https://doi.org/10.1093/nar/gkaa1063

Article  CAS  PubMed  Google Scholar 

Zhang Y, Deb DK, Kong J, Ning G (2009) Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol 297:F791-801. https://doi.org/10.1152/ajprenal.00247.2009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Percie du Sert N, Ahluwalia A (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 18:e3000411. https://doi.org/10.1371/journal.pbio.3000411

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han P, Weng W, Chen Y, Cai Y (2020) Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice. Am J Transl Res 12:5015–5031

CAS  PubMed  PubMed Central  Google Scholar 

Yu FY, Xie CQ, Sun JT, Peng W (2018) Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3. Life Sci 202:11–20. https://doi.org/10.1016/j.lfs.2018.03.042

Article  CAS  PubMed  Google Scholar 

Li F, Yao Y, Huang H, Hao H (2018) Xanthohumol attenuates cisplatin-induced nephrotoxicity through inhibiting NF-κB and activating Nrf2 signaling pathways. Int Immunopharmacol 61:277–282. https://doi.org/10.1016/j.intimp.2018.05.017

Article  CAS  PubMed  Google Scholar 

Li F, Zhang J, Luo L, Hu J (2023) Protective effects of xanthohumol against diabetic nephropathy in a mouse model. Kidney Blood Press Res 48:92–101. https://doi.org/10.1159/000528650

Article  CAS  PubMed  Google Scholar 

Wang Q, Chen T, Shuqing Z, Yu L (2023) Xanthohumol relieves arthritis pain in mice by suppressing mitochondrial-mediated inflammation. Mol Pain 19:17448069231204052. https://doi.org/10.1177/17448069231204051

Article